These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 30848917

  • 1. Topography of Simulated Intestinal Equilibrium Solubility.
    Dunn C, Perrier J, Khadra I, Wilson CG, Halbert GW.
    Mol Pharm; 2019 May 06; 16(5):1890-1905. PubMed ID: 30848917
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
    McPherson S, Perrier J, Dunn C, Khadra I, Davidson S, Ainousah B, Wilson CG, Halbert G.
    Eur J Pharm Biopharm; 2020 May 06; 150():14-23. PubMed ID: 32035969
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments.
    Madsen CM, Feng KI, Leithead A, Canfield N, Jørgensen SA, Müllertz A, Rades T.
    Eur J Pharm Sci; 2018 Jan 01; 111():311-319. PubMed ID: 28986196
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fasted intestinal solubility limits and distributions applied to the biopharmaceutics and developability classification systems.
    Abuhassan Q, Khadra I, Pyper K, Augustijns P, Brouwers J, Halbert GW.
    Eur J Pharm Biopharm; 2022 Jan 01; 170():160-169. PubMed ID: 34923138
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids.
    Abuhassan Q, Khadra I, Pyper K, Augustijns P, Brouwers J, Halbert GW.
    Eur J Pharm Biopharm; 2022 Jul 01; 176():108-121. PubMed ID: 35605926
    [Abstract] [Full Text] [Related]

  • 17. Impact of phospholipid digests and bile acid pool variations on the crystallization of atazanavir from supersaturated solutions.
    Enright EF, Joyce SA, Gahan CGM, Taylor LS.
    Eur J Pharm Biopharm; 2020 Aug 01; 153():68-83. PubMed ID: 32473291
    [Abstract] [Full Text] [Related]

  • 18. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K.
    AAPS PharmSciTech; 2012 Jun 01; 13(2):637-46. PubMed ID: 22547370
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.